RA CAPITAL MANAGEMENT L.P. 13D and 13G filings for Kala Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-06-03 5:11 pm Sale | 2022-06-02 | 13D | Kala Pharmaceuticals, Inc. KALA | RA CAPITAL MANAGEMENT L.P. | 136,515 4.700% | -111,277 (-44.91%) | Filing |
| 2022-05-31 5:31 pm Sale | 2022-05-26 | 13D | Kala Pharmaceuticals, Inc. KALA | RA CAPITAL MANAGEMENT L.P. | 247,792 8.530% | -74,020 (-23.00%) | Filing |
| 2022-05-25 5:12 pm Sale | 2022-05-23 | 13D | Kala Pharmaceuticals, Inc. KALA | RA CAPITAL MANAGEMENT L.P. | 321,812 11.080% | -114,773 (-26.29%) | Filing |
| 2022-04-01 4:30 pm Sale | 2022-03-30 | 13D | Kala Pharmaceuticals, Inc. KALA | RA CAPITAL MANAGEMENT L.P. | 436,585 15.030% | -1,877 (-0.43%) | Filing |
| 2021-10-28 4:23 pm Purchase | 2009-02-28 | 13D | Kala Pharmaceuticals, Inc. KALA | RA CAPITAL MANAGEMENT L.P. | 438,461 16.850% | 3,477 (+0.80%) | Filing |
| 2020-03-13 5:19 pm Purchase | 2009-02-28 | 13D | Kala Pharmaceuticals, Inc. KALA | RA CAPITAL MANAGEMENT L.P. | 434,985 19.900% | 253,485 (+139.66%) | Filing |